NCT02921763 - A Survey on Efficacy and Safety in Patients With Endometriosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 23, 2016

Primary Completion Date

September 21, 2017

Study Completion Date

October 13, 2017

Conditions

Endometriosis

Interventions

DRUG

Dydrogesterone

Trial Locations (15)

Mylan Investigational Site G, Tokyo

Mylan Investigational Site N, Tokyo

Mylan Investigational Site C, Kyoto

Mylan Investigational Site D, Saitama

Mylan Investigational Site M, Okayama

Mylan Investigational Site H, Kyoto

Mylan Investigational Site A, Kamigyō-ku

Mylan Investigational Site I, Kyoto

Mylan Investigational Site K, Kyoto

Mylan Investigational Site F, Kyoto

Mylan Investigational Site J, Tokyo

Mylan Investigational Site B, Bunkyō

Mylan Investigational Site E, Kyoto

Mylan Investigational Site L, Kyoto

Mylan Investigational Site O, Tokushima